Blog · Extended-State Research
Extended-state DMT — "DMTx" — is an experimental research method for holding a person in the DMT state far longer than a single dose allows, using continuous intravenous infusion under medical monitoring. The best-known work is at Imperial College London. It is not proven therapy and not a guaranteed spiritual breakthrough: it is a protocol for studying an unusual state of consciousness with more time, structure and measurement than a short session allows.
DMT, or N,N-dimethyltryptamine, is a psychedelic compound found in some plants and produced in small amounts in mammals. Given as a single dose, the experience is typically very brief and intense — vivid imagery, altered body perception, strong emotion, a sense of entering a complex inner environment. Those reports are subjective. They are interesting, but they are not evidence that any particular metaphysical claim is true.
The problem for researchers is that ordinary DMT is fast: the main effects can peak and fade within minutes, which makes the state hard to study carefully. DMTx tries to solve that timing problem. In the Imperial College model, DMT is administered through a continuous infusion after an initial dose, aiming to reach and maintain a more stable level of effect for longer while medical monitoring and research observation continue. The logic is similar to how anaesthesia research uses infusion models — not because the state is the same, but because controlled dosing over time lets a state be studied more carefully than a single rapid peak.
For Ashta, the interest is methodological, not promotional. We do not present DMTx as a cure or as proof of anything supernatural. Extended-state DMT may give researchers a longer window in which to study attention, memory, voice, physiology, emotional processing, group context and meaning-making before, during and after a powerful altered state. Our frame is deliberately de-wooed: if someone reports entities or cosmic truths, the report is recorded as a report, not treated as proof. The question is not "what should we believe?" but "what can be measured, compared, replicated, or falsified?"
That is where the instrument panel matters — clusters of eight, tracked goals, voice biomarkers, heart-rate variability, structured reflection, and pre-registered designs. Where legally and ethically available through appropriate partners, DMTx would be studied as one possible extended-state condition among others, with the focus on what changes can be observed over time, what does not change, and which claims fail under better measurement. The standing model for a legal, physician-supervised DMTx setting is described on our retreats page, and the researcher who has spent the most documented time inside the extended state, Carl Hayden Smith, is part of that lineage.
This distinction matters because psychedelic culture often overclaims. People may have life-changing experiences, but that does not automatically establish clinical benefit, durable behavioural change, or external truth. A meaningful experience can still be misunderstood; a powerful story can still be wrong; a beautiful interpretation can still fail a blinded test. DMTx is still early. It is not a consumer wellness shortcut and not something to improvise — it involves a powerful psychedelic state and should only be approached within lawful, ethical, medically supervised research or clinical settings. No miracles promised, no mechanisms asserted without evidence, no therapeutic claims without clinical proof.
